Role of Intestinal Microbiota in Ulcerative Colitis
Role of Intestinal Microbiota in Ulcerative Colitis Role of Intestinal Microbiota in Ulcerative Colitis
The composition of the species of lactobacilli and bifidobacteria derived from UC patients could also be the reason for the lower level found in the mucus in vitro, since expression of adhesion molecules and mucus‐degrading enzymes is likely to be species specific. In the present study, the content of three Bifidobacterium species in the M‐SHIME vessels for the three microbiota (healthy subjects, UC patients in remission or relapse) sources was measured. The ability to colonize the mucus was reduced for B. bifidum and B. adolescentis originating from UC patients in relapse while B. adolescentis and B. pseudocatenulatum was reduced in the mucus compared to the lumen in the vessels with microbiota derived from UC patients in remission. No significant difference in the lumen and mucus content of the three Bifidobacterium species derived from healthy subjects could be observed. This could imply that the Bifidobacterium species that are able to colonize the mucus may differ depending on disease state origin, resulting in different species composition. In agreement with this, previous study has shown that the ability of different lactic acid bacteria strains to adhere to intestinal mucus was disease‐specific; hence the inflammatory state in UC may influence mucosal adhesion [45]. In the present study, the content of C. coccoides group and C. leptum subgroup derived from UC patients in relapse was significantly lower in the mucus than in the lumen. This was also true for the C. leptum group and F. prausnitzii derived from UC patients in remission (Table 2). Depletion of the two clostridial groups including F. prausnitzii in UC patients has previously been described in fecal samples [57,58]. In contrast, E. rectale demonstrated high capacity for adhesion to mucus in the present study, particularly when derived from UC patients in remission or from healthy subjects. This was also the case for Roseburia spp. derived from UC patients in remission (Table 3). Little is known regarding the ability of the species from clostridial groups to colonize the mucus. However, our results imply that some species have high capacity for adhesion depending on microbiota sources. Clostridial groups such as C. coccoides group and C. leptum subgroup are believed to be important for colon health and immune homeostasis. This was demonstrated by Atarashi et al. [3], who showed that C. coccoides group and C. leptum subgroup can stimulate mucosal immune regulatory responses through activation of regulatory T cells. Additionally, C. coccoides group and C. leptum subgroup include several bacteria that are able to produce butyrate, which has shown to down regulate pro‐inflammatory cytokine production via inhibition of NF‐κβ and as a result stimulate an anti‐inflammatory state in the colon [18,55]. This suggests 12
that C. coccoides group and C. leptum subgroup are important commensal bacteria that if depleted in the mucus could have a consequence for colonic health. We conclude that the mucosal bacterial community differs from that of the luminal. The difference was ascribed to butyrate‐producing bacteria and lactic acid bacteria and was dominating the inter‐individual sample variation. Bifidobacteria and lactobacilli derived from UC patients had decreased capacity to colonize the mucus, which may either be due to changed expression of adhesion molecules and/or to the composition of species within the genera Bifidobacterium and Lactobacillus. Our findings indicates that the ability of fecal bacteria to colonize the mucus is reduced in UC patients in relapse but only to some extent in UC patients in remission, which implies that the inflammatory state may have an influence on microbial adhesion capacity. However, further in vivo studies are needed to confirm these findings. 13
- Page 49 and 50: Theoretical part 5. Production of p
- Page 51: Methodology part
- Page 54 and 55: Methodology part 6. Methodology, co
- Page 56 and 57: Methodology part 6. Methodology, co
- Page 58 and 59: Methodology part 6. Methodology, co
- Page 60 and 61: Introduction Methodology part 42 Pa
- Page 62 and 63: Abstract Background Detailed knowle
- Page 64 and 65: depending the level of disease acti
- Page 66 and 67: in 1 x TAE at 60 °C for 16 h at 36
- Page 68 and 69: Statistics PCA were generated by SA
- Page 70 and 71: The PCA of the Gram‐positive bact
- Page 72 and 73: layer of UC patients and found that
- Page 74 and 75: Acknowledgements The authors thank
- Page 76 and 77: Table 2 ‐ 16S rRNA gene and 16S
- Page 78 and 79: 1. Firmicutes phylum 2. Bacteroidet
- Page 80 and 81: Supplementary Figure S1. Dice clust
- Page 82 and 83: Reference List 1. Ahmed S, Macfarla
- Page 84 and 85: 32. Matsuki T, Watanabe K, Fujimoto
- Page 87 and 88: Methodology part Paper 2 Fecal lact
- Page 89 and 90: Fecal lactobacilli and bifidobacter
- Page 91 and 92: Introduction The mucus layer lining
- Page 93 and 94: efore enrolment and there was no si
- Page 95 and 96: (Bio‐Rad Labs, Hercules, Californ
- Page 97 and 98: Microbial community analysis using
- Page 99: difference from the luminal microbi
- Page 103 and 104: Table 1 ‐ 16S rRNA gene of phylum
- Page 105 and 106: Table 2 ‐ Preference of bacterial
- Page 107 and 108: Figure 1. A) Schematic overview of
- Page 109 and 110: A. B. Figure 3. Principal component
- Page 111 and 112: 15. Fooks LJ, Gibson GR. (2002) In
- Page 113 and 114: 47. Ouwehand AC, Suomalainen T, Tol
- Page 115 and 116: Methodology part Paper 3 Paper 3 In
- Page 117 and 118: APPLIED AND ENVIRONMENTAL MICROBIOL
- Page 119 and 120: 8338 VIGSNÆS ET AL. APPL. ENVIRON.
- Page 121 and 122: 8340 VIGSNÆS ET AL. APPL. ENVIRON.
- Page 123 and 124: 8342 VIGSNÆS ET AL. APPL. ENVIRON.
- Page 125: 8344 VIGSNÆS ET AL. APPL. ENVIRON.
- Page 128 and 129: Methodology part Introduction The a
- Page 130 and 131: Journal of Agricultural and Food Ch
- Page 132 and 133: Journal of Agricultural and Food Ch
- Page 134 and 135: Journal of Agricultural and Food Ch
- Page 136 and 137: Journal of Agricultural and Food Ch
- Page 139 and 140: Methodology part Paper 5 Paper 5 Ma
- Page 141 and 142: Appl Microbiol Biotechnol (2011) 90
- Page 143 and 144: Appl Microbiol Biotechnol (2011) 90
- Page 145 and 146: Appl Microbiol Biotechnol (2011) 90
- Page 147 and 148: Appl Microbiol Biotechnol (2011) 90
- Page 149 and 150: Appl Microbiol Biotechnol (2011) 90
that C. coccoides group and C. leptum subgroup are important commensal bacteria that if<br />
depleted <strong>in</strong> the mucus could have a consequence for colonic health.<br />
We conclude that the mucosal bacterial community differs from that <strong>of</strong> the lum<strong>in</strong>al. The<br />
difference was ascribed to butyrate‐produc<strong>in</strong>g bacteria and lactic acid bacteria and was<br />
dom<strong>in</strong>at<strong>in</strong>g the <strong>in</strong>ter‐<strong>in</strong>dividual sample variation. Bifidobacteria and lactobacilli derived from UC<br />
patients had decreased capacity to colonize the mucus, which may either be due to changed<br />
expression <strong>of</strong> adhesion molecules and/or to the composition <strong>of</strong> species with<strong>in</strong> the genera<br />
Bifidobacterium and Lactobacillus. Our f<strong>in</strong>d<strong>in</strong>gs <strong>in</strong>dicates that the ability <strong>of</strong> fecal bacteria to<br />
colonize the mucus is reduced <strong>in</strong> UC patients <strong>in</strong> relapse but only to some extent <strong>in</strong> UC patients <strong>in</strong><br />
remission, which implies that the <strong>in</strong>flammatory state may have an <strong>in</strong>fluence on microbial adhesion<br />
capacity. However, further <strong>in</strong> vivo studies are needed to confirm these f<strong>in</strong>d<strong>in</strong>gs.<br />
13